Amryt Pharma PLC (AMYT)
Amryt Pharma has a market cap or net worth of $685.51 million. The enterprise value is $736.21 million.
The next earnings date is Thursday, November 4, 2021 before market open.
|Estimated Earnings Date||Nov 4, 2021|
Amryt Pharma has 63.38 million shares outstanding. The number of shares has increased by 4.48% in one year.
|Shares Change (YoY)||+4.48%|
|Shares Change (QoQ)||+0.33%|
|Owned by Insiders (%)||n/a|
|Owned by Institutions (%)||24.76%|
The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of 15.84.
|EV / Earnings||n/a|
|EV / Sales||3.63|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||15.84|
The company has a current ratio of 2.19, with a Debt / Equity ratio of 3.93.
|Debt / Equity||3.93|
|Debt / EBITDA||-14.49|
|Debt / FCF||4.17|
|Return on Equity (ROE)||-132.20%|
|Return on Assets (ROA)||-15.40%|
|Return on Capital (ROIC)||-31.90%|
|Revenue Per Employee||$1.12M|
|Profits Per Employee||-$443,940|
In the past 12 months, Amryt Pharma has paid $4.46 million in taxes.
|Effective Tax Rate||-5.84%|
Stock Price Statistics
The stock price has decreased by -12.75% in the last 52 weeks. The beta is 0.11, so Amryt Pharma's price volatility has been lower than the market average.
|52-Week Price Change||-12.75%|
|50-Day Moving Average||11.67|
|200-Day Moving Average||11.76|
|Average Volume (30 Days)||81,104|
Short Selling Information
|Short % of Shares Out||0.50%|
|Short % of Float||1.54%|
|Short Ratio (days to cover)||4.08|
In the last 12 months, Amryt Pharma had revenue of $203.04 million and -$80.80 million in losses. Earnings per share was -$2.39.
|Earnings Per Share (EPS)||-$2.39|
The company has $142.95 million in cash and $193.65 million in debt, giving a net cash position of -$50.70 million or -$0.80 per share.
|Cash & Cash Equivalents||142.95M|
|Net Cash Per Share||-$0.80|
|Book Value Per Share||0.78|
In the last 12 months, operating cash flow was $49.65 million and capital expenditures -$3.19 million, giving a free cash flow of $46.47 million.
|Operating Cash Flow||49.65M|
|Free Cash Flow||46.47M|
|FCF Per Share||$0.73|
Gross margin is 47.50%, with operating and profit margins of -8.29% and -39.79%.
Dividends & Yields
Amryt Pharma does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|